MEGA Osteocap Calcitriol BP 0.25 mcg (10x10s)

DESCRIPTION

Treatment for disease caused by disturbances in calcium metabolism in consequence of reduced endogenous production of 1,25-dihydroxyvitamin D: Osteoporosis. Renal osteodystrophy in patients undergoing dialysis, hypoprathyroidism (post-surgical, idiopathic & pseudohypoparathyroidism), vitamin D-dependent rickets, hypophosphatemic vitamin D-resistant rickets.

COMPOSITION:

Calcitriol  0.25 mcg

INDICATIONS:

Postmenopausal osteoporosis, Renal osteodystrophy in patients with Chronic Renal Failure particularly those undergoing dialysis, Post-surgical hypoparthyroidism

DOSE:

As directed by physician